نتایج جستجو برای: multidrug resistant mycobacterium tuberculosis mdr

تعداد نتایج: 311140  

Journal: :Japanese journal of infectious diseases 2012
Caie Yang Hong Lei Di Wang Xianghong Meng Jufang He Aihua Tong Lei Zhu Ying Jiang Mei Dong

The in vitro activity of linezolid was evaluated against 84 clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, isolated from the center for tuberculosis research and treatment of the Chinese army. Linezolid showed excellent activity, with minimum inhibitory concentrations (MICs) of 0.125-0.5 μg/mL against all te...

Journal: :Enfermedades infecciosas y microbiologia clinica 2015
Samantha Flores-Treviño Rayo Morfín-Otero Eduardo Rodríguez-Noriega Esteban González-Díaz Héctor Raúl Pérez-Gómez Soraya Mendoza-Olazarán Isaías Balderas-Rentería Gloria María González Elvira Garza-González

INTRODUCTION The emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis strains has become a worldwide health care problem, making treatment of tuberculosis difficult. The aim of this study was to determine phenotypic resistance and gene mutations associated with MDR of clinical isolates of Mycobacterium tuberculosis from Guadalajara, Mexico. METHODS One hundred and five isolates w...

Journal: :iranian journal of microbiology 0
p tahmasebi mycobacteriology research centre, national research institute of tuberculosis and lung disease (nritld), who & :union: collaborating centre for tb & lung diseases, darabad, tehran, iran. p farnia mycobacteriology research centre, national research institute of tuberculosis and lung disease (nritld), who & :union: collaborating centre for tb & lung diseases, darabad, tehran, iran. fm sheikholslami mycobacteriology research centre, national research institute of tuberculosis and lung disease (nritld), who & :union: collaborating centre for tb & lung diseases, darabad, tehran, iran. aa velayati mycobacteriology research centre, national research institute of tuberculosis and lung disease (nritld), who & :union: collaborating centre for tb & lung diseases, darabad, tehran, iran.

background and objectives: resistance in mycobacterium tuberculosis is caused by mutations in genes encoding drug targets. investigators have already demonstrated the existence of mutations in codons 88 to 94 in the gyra gene and also in codons 1400, 1401, and 1483 of rrs gene among extensively and extremely drug resistant tuberculosis (xdr & xxdr-tb) strains. the aim of this study was to ident...

Journal: :Antimicrobial agents and chemotherapy 2011
Yasraba Rafiq Kauser Jabeen Rumina Hasan Sana Jafri Rabia Laiq Faisal Malik Rafique Mangi Abid Channa Zahra Hasan

A fluoroquinolone (FQ) resistance rate of 5.9% is reported in 205 Mycobacterium tuberculosis isolates from patients presenting to field clinics in Karachi, Pakistan (2006 to 2009). FQ resistance among multidrug-resistant (MDR) strains was 11.1% (5/45), and it was 4.9% (5/103) in M. tuberculosis strains susceptible to all first-line agents. Spoligotyping of resistant strains did not show dominan...

Aliasghar Farazi, Fatemeh Katebi, Masoomeh Sofian, Nader Zarrinfar, Roohollah Keshavarz, Seyed Davood Hoseini,

Background: One of the fundamental issues of infectious disease treatment is drug resistance. The aim of the present study was to investigate the first-line anti-tuberculosis drug resistance rates and determine the risk factors related to multidrug resistant mycobacterium tuberculosis.Methods: From March 2011 to September 2012, mycobacterial strains were collected from one hundred fifteen diagn...

Journal: :Antimicrobial agents and chemotherapy 1994
T P Kanyok M V Reddy J Chinnaswamy L H Danziger P R Gangadharam

Encouraged by in vitro results, we have assessed the in vivo activity of paromomycin (PRM) against Mycobacterium tuberculosis, multidrug-resistant (MDR) M. tuberculosis (resistant to isoniazid, rifampin, and streptomycin), and Mycobacterium avium complex in C57BL/6 mice and their beige counterparts. In all these experiments, PRM was effective in preventing mortality from a mycobacterial infecti...

2015
Russell R. Kempker Maia Kipiani Veriko Mirtskhulava Nestani Tukvadze Matthew J. Magee Henry M. Blumberg

Rates and risk factors for acquired drug resistance and association with outcomes among patients with multidrug-resistant tuberculosis (MDR TB) are not well defined. In an MDR TB cohort from the country of Georgia, drug susceptibility testing for second-line drugs (SLDs) was performed at baseline and every third month. Acquired resistance was defined as any SLD whose status changed from suscept...

Journal: :The Lancet. Infectious diseases 2013
Ibrahim Abubakar Matteo Zignol Dennis Falzon Mario Raviglione Lucica Ditiu Susan Masham Ifedayo Adetifa Nathan Ford Helen Cox Stephen D Lawn Ben J Marais Timothy D McHugh Peter Mwaba Matthew Bates Marc Lipman Lynn Zijenah Simon Logan Ruth McNerney Adam Zumla Krishna Sarda Payam Nahid Michael Hoelscher Michel Pletschette Ziad A Memish Peter Kim Richard Hafner Stewart Cole Giovanni Battista Migliori Markus Maeurer Marco Schito Alimuddin Zumla

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health conc...

Journal: :Antimicrobial agents and chemotherapy 2011
J W C Alffenaar T van der Laan S Simons T S van der Werf P J van de Kasteele H de Neeling D van Soolingen

Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evaluated by the MGIT 960 system. The isolates had various susceptibilities to isoniazid (INH), rifampin, ethambutol, and streptomycin. The mean MIC for PNU-100480 was 3.2 times lower than that for linezolid. Therefore, PNU-100480 is a promising candidate to be developed further as an adjunct in the t...

2013
Adelina Jiménez-Arellanes Julieta Luna-Herrera Ricardo Ruiz-Nicolás Jorge Cornejo-Garrido Amparo Tapia Lilián Yépez-Mulia

BACKGROUND Persea americana seeds are widely used in traditional Mexican medicine to treat rheumatism, asthma, infectious processes as well as diarrhea and dysentery caused by intestinal parasites. METHODS The chloroformic and ethanolic extracts of P. americana seeds were prepared by maceration and their amoebicidal, giardicidal and trichomonicidal activity was evaluated. These extracts were ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید